Cloning of cytochrome P-450 2C9 cDNA from human liver and its expression in CHL cells

World Journal of Gastroenterology

Volumn 8, Issue 2, 2002, Pages 318-322

  Zhu, Ge Jian ^a   Yu, Ying Nian ^a   Li, Xin ^a   Qian, Yu Li ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 2C9; DRUG; DRUG METABOLITE; DRUG METABOLIZING ENZYME; HYDROXYTOLBUTAMIDE; RNA; TOLBUTAMIDE; TOLBUTAMIDE HYDROXYLASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIUM; CATALYSIS; CELL LINE; CLONING VECTOR; CONTROLLED STUDY; DNA SEQUENCE; DRUG METABOLISM; DRUG RESEARCH; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ENZYME STABILITY; EXPRESSION VECTOR; GENETIC CODE; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMAL CELL; MOLECULAR CLONING; NONHUMAN; OXIDATION KINETICS; PARENT; PREDICTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSGENICS; WILD TYPE; YEAST;

EID: 0036236130     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i2.318     Document Type: Article

References (49)

1. Cytochromes P450 and metabolism of xenobiotics
2. Cytochrome P450 and the individuality of species
3. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily
4. CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone
5. In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: Correlation with CYP2 C9 genotype and in-vivo pharmacokinetics
6. Major role of human liver microsomal cytochrome P450 2C9 (CYP2 C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor
7. Role of cytochrome P4502C9 in irbesartan oxidation by human liver microsomes
8. Cytochrome P450 2C9: An enzyme of major importance in human drug metabolism
9. Construction of HCV-core gene vector and its expression in cholangiocarcinoma
10. Expression, purification and immuno-characteristics of recombinant UreB protein of H. pylori
11. High-level expression of human calmodulin in E. coli and its effects on cell proliferation
12. Cloning and sequence analysis of human genomic DNA of augmenter of liver regeneration
13. Construction of eukaryotic expression vector of HBV x gene
14. Cloning and expression of HLA-B7 gene
15. Cloning and identification of an angiostatic molecule IP10/crg-2
16. Construction of hepatocyte growth factor expression vector and detection of expression in human hepatocytes
17. Tetracycline controlled DT/VEGF system gene therapy mediated by adenovirus vector
18. Inhibitory effects of human cholangiocarcinoma cell line by recombinant adenoviruses P16 with CDDP
19. The use of heterologously expressed drug metabolizing enzymes-state of the art and prospects for the future
20. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli
21. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: Application of genetically engineered Salmonella typhimurium YG7108 expression each form of CYP together with human NADPH-cytochrome P450 reductase
22. Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans
23. High expression of human CYP2C in immortalized human liver epithelial cells
24. Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology
25. Stable expression of human cytochrome CYP2B6 and CYP1A1 in chinese hamster CHL cells: Their use in micronucleus assays
26. Cloning of human cytochrome P450 2A6 cDNA and its expression in mammalian cells
27. Establishment of transgenic cell line CHL-3A4 and its metabolic activation
28. Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells
29. Measurement of cytochrome P-450 in the presence of large amounts of contaminating hemoglobin and methemoglobin
30. Determination of tolbutamide hydroxylation in rat liver microsomes by high-performance liquid chromatography: Effect of psychoactive drugs on in vitro activity
31. Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity
32. Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR
33. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs
34. P450-expression in brain tumors
35. The R144C change in the CYP2 C9 * 2 allele alters interaction of the cytochrome P450 with NADPH: Cytochrome P450 oxidoreductase
36. Association of polymorphisms in the cytochrome P450 CYP2 C9 with warfarin dose requirement and risk of breeding complications
37. CYP2 C9 Ile359 and Leu359 variants: Enzyme kinetic study with seven substrates
38. Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9 * 3 allele
39. Role of CYP2 C9 polymorphism in losartan oxidation
40. Torsemide metabolism by CYP2 C9 variants and other human CYP2C subfamily enzymes
41. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: Genetic analysis of the CYP2 C9 locus
42. Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis
43. Identification and functional characterization of a new CYP2C9 variant (CYP2C9 * 5) expressed among African Americans
44. Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin
45. Genetic polymorphisms and functional characterization of the 5′-flanking region of the human CYP2 C9 gene: In vitro and in vivo studies
46. Incorporation of exogenous heme into hepatic cytochrome P-450 in vivo
47. Characterization of CYP2C19 and CYP2C9 from human liver: Respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations
48. A comparison of aroclor 1254-induced and uninduced rat liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4′-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6β-hydroxylation